ArticleFrontiers in medicine2023
A prospective multicenter clinical research study validating the effectiveness and safety of a chest X-ray-based pulmonary tuberculosis screening software JF CXR-1 built on a convolutional neural network algorithm.
Article in Frontiers in medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 8 citations in OpenAlex.
- Artificial Intelligence Across the Radiology Workflow: A Nine-Stage Narrative Review.Diagnostics (Basel, Switzerland) · 2026Review
- Artificial Intelligence-Assisted Pathogen Detection: Algorithms, Biosensing Platforms, and Applications.Biosensors · 2026Review
- Article
- PulmoX-Net: a channel-attention enhanced deep learning model for multi-class pulmonary pathology classification in chest radiography.Frontiers in medicine · 2026Article
- AI-Powered Chest X-Ray for Diagnosing Pulmonary Tuberculosis in County and Township Health Care Facilities in Yichang: Retrospective, Real-World Study.Journal of medical Internet research · 2025Article
- Performance of Computer-Aided Detection Software in Tuberculosis Case Finding in Township Health Centers in China.Chronic diseases and translational medicine · 2025Article
- A systematic review and meta-analysis of artificial intelligence software for tuberculosis diagnosis using chest X-ray imaging.Journal of thoracic disease · 2025Article
- Advancing Medical Imaging Research Through Standardization: The Path to Rapid Development, Rigorous Validation, and Robust Reproducibility.Investigative radiology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 6 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chest radiography (chest X-ray or CXR) plays an important role in the early detection of active pulmonary tuberculosis (TB). In areas with a high TB burden that require urgent screening, there is often a shortage of radiologists available to interpret the X-ray results. Computer-aided detection (CAD) software employed with artificial intelligence (AI) systems may have the potential to solve this problem. Objective: We validated the effectiveness and safety of pulmonary tuberculosis imaging screening software that is based on a convolutional neural network algorithm. Methods: We conducted prospective multicenter clinical research to validate the performance of pulmonary tuberculosis imaging screening software (JF CXR-1). Volunteers under the age of 15 years, both with or without suspicion of pulmonary tuberculosis, were recruited for CXR photography. The software reported a probability score of TB for each participant. The results were compared with those reported by radiologists. We measured sensitivity, specificity, consistency rate, and the area under the receiver operating characteristic curves (AUC) for the diagnosis of tuberculosis. Besides, adverse events (AE) and severe adverse events (SAE) were also evaluated. Results: The clinical research was conducted in six general infectious disease hospitals across China. A total of 1,165 participants were enrolled, and 1,161 were enrolled in the full analysis set (FAS). Men accounted for 60.0% (697/1,161). Compared to the results from radiologists on the board, the software showed a sensitivity of 94.2% (95% CI: 92.0-95.8%) and a specificity of 91.2% (95% CI: 88.5-93.2%). The consistency rate was 92.7% (91.1-94.1%), with a Kappa value of 0.854 ( Conclusion: The software for tuberculosis screening based on a convolutional neural network algorithm is effective and safe. It is a potential candidate for solving tuberculosis screening problems in areas lacking radiologists with a high TB burden.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.